121 related articles for article (PubMed ID: 16721725)
1. Tobacco smoking, NAT2 acetylation genotype and breast cancer risk.
Lissowska J; Brinton LA; Zatonski W; Blair A; Bardin-Mikolajczak A; Peplonska B; Sherman ME; Szeszenia-Dabrowska N; Chanock S; García-Closas M
Int J Cancer; 2006 Oct; 119(8):1961-9. PubMed ID: 16721725
[TBL] [Abstract][Full Text] [Related]
2. N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer.
Rabstein S; Brüning T; Harth V; Fischer HP; Haas S; Weiss T; Spickenheuer A; Pierl C; Justenhoven C; Illig T; Vollmert C; Baisch C; Ko YD; Hamann U; Brauch H; Pesch B;
Eur J Cancer Prev; 2010 Mar; 19(2):100-9. PubMed ID: 19996973
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.
Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321
[TBL] [Abstract][Full Text] [Related]
4. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis.
Ambrosone CB; Kropp S; Yang J; Yao S; Shields PG; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):15-26. PubMed ID: 18187392
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype.
Delfino RJ; Smith C; West JG; Lin HJ; White E; Liao SY; Gim JS; Ma HL; Butler J; Anton-Culver H
Pharmacogenetics; 2000 Jul; 10(5):461-9. PubMed ID: 10898115
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer.
Hunter DJ; Hankinson SE; Hough H; Gertig DM; Garcia-Closas M; Spiegelman D; Manson JE; Colditz GA; Willett WC; Speizer FE; Kelsey K
Carcinogenesis; 1997 Nov; 18(11):2127-32. PubMed ID: 9395212
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk.
Millikan RC; Pittman GS; Newman B; Tse CK; Selmin O; Rockhill B; Savitz D; Moorman PG; Bell DA
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):371-8. PubMed ID: 9610785
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype.
Morabia A; Bernstein MS; Bouchardy I; Kurtz J; Morris MA
Am J Epidemiol; 2000 Aug; 152(3):226-32. PubMed ID: 10933269
[TBL] [Abstract][Full Text] [Related]
11. [The relationship between passive smoking, breast cancer risk and n-acetyltransferase 2 (NAT2)].
Avraham Z; Baron-Epel O; Boker LK
Harefuah; 2014; 153(3-4):171-5, 238. PubMed ID: 24791559
[TBL] [Abstract][Full Text] [Related]
12. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
[TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
[TBL] [Abstract][Full Text] [Related]
14. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer.
Slattery ML; Edwards S; Curtin K; Schaffer D; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):882-9. PubMed ID: 14504199
[TBL] [Abstract][Full Text] [Related]
15. A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology.
Lash TL; Bradbury BD; Wilk JB; Aschengrau A
Breast Cancer Res; 2005; 7(3):R385-93. PubMed ID: 15987434
[TBL] [Abstract][Full Text] [Related]
16. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
[TBL] [Abstract][Full Text] [Related]
17. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer.
Rebbeck TR; Rogatko A; Viana MA
Genet Test; 1997-1998; 1(3):157-64. PubMed ID: 10464641
[TBL] [Abstract][Full Text] [Related]
19. Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer.
Conlon MS; Johnson KC; Bewick MA; Lafrenie RM; Donner A
Cancer Epidemiol; 2010 Apr; 34(2):142-9. PubMed ID: 20197243
[TBL] [Abstract][Full Text] [Related]
20. Passive smoking, NAT2 polymorphism, and breast cancer risk in Israeli Arab women: a case-control study.
Regev-Avraham Z; Baron-Epel O; Hammond SK; Keinan-Boker L
Breast Cancer; 2018 Mar; 25(2):176-184. PubMed ID: 29071579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
